Amneal Introduces First Generic for Mephyton(R) (Phytonadione) Tablets, 5mg

BRIDGEWATER, N.J., May 15, 2018 -- (Healthcare Sales & Marketing Network) -- Amneal Pharmaceuticals, Inc. (NYSE: AMRX) has launched Phytonadione Tablets, USP, 5 mg, the first AB-rated therapeutic equivalent for Mephyton®. The product is available in ... Biopharmaceuticals, Generics, Product Launch Amneal Pharmaceuticals, Mephyton, Phytonadione
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news